202 related articles for article (PubMed ID: 28492540)
1. NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer.
Feng X; Xu X; Xiao X; Zou K; Yu W; Wu J; Tang R; Gao Y; Hao J; Zhao X; Liao Y; Chen Y; Huang W; Guo W; Kang L; Deng W
Cell Death Dis; 2017 May; 8(5):e2783. PubMed ID: 28492540
[TBL] [Abstract][Full Text] [Related]
2. A novel tricomplex of BRCA1, Nmi, and c-Myc inhibits c-Myc-induced human telomerase reverse transcriptase gene (hTERT) promoter activity in breast cancer.
Li H; Lee TH; Avraham H
J Biol Chem; 2002 Jun; 277(23):20965-73. PubMed ID: 11916966
[TBL] [Abstract][Full Text] [Related]
3. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
4. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
5. Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA; Mitra A; Xi Y; Ju J; Scammell J; Shevde LA; Samant RS
Int J Cancer; 2009 Aug; 125(3):556-64. PubMed ID: 19358268
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CXCR7 inhibits proliferative capacity and stem cell-like properties in breast cancer stem cells.
Tang X; Li X; Li Z; Liu Y; Yao L; Song S; Yang H; Li C
Tumour Biol; 2016 Oct; 37(10):13425-13433. PubMed ID: 27460092
[TBL] [Abstract][Full Text] [Related]
7. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
8. The involvement of HER2 and p53 status in the regulation of telomerase in irradiated breast cancer cells.
Papanikolaou V; Iliopoulos D; Dimou I; Dubos S; Tsougos I; Theodorou K; Kitsiou-Tzeli S; Tsezou A
Int J Oncol; 2009 Nov; 35(5):1141-9. PubMed ID: 19787269
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.
Chung SS; Aroh C; Vadgama JV
PLoS One; 2013; 8(12):e83971. PubMed ID: 24386318
[TBL] [Abstract][Full Text] [Related]
10. microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer.
Rostas JW; Pruitt HC; Metge BJ; Mitra A; Bailey SK; Bae S; Singh KP; Devine DJ; Dyess DL; Richards WO; Tucker JA; Shevde LA; Samant RS
Mol Cancer; 2014 Aug; 13():200. PubMed ID: 25174825
[TBL] [Abstract][Full Text] [Related]
11. A positive feedback loop between Wnt/β-catenin signaling and hTERT regulates the cancer stem cell-like traits in radioresistant nasopharyngeal carcinoma cells.
Chen K; Chen L; Li L; Qu S; Yu B; Sun Y; Wan F; Chen X; Liang R; Zhu X
J Cell Biochem; 2020 Nov; 121(11):4612-4622. PubMed ID: 32065421
[TBL] [Abstract][Full Text] [Related]
12. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
13. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
14. Pterostilbene down-regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc.
Daniel M; Tollefsbol TO
J Cell Biochem; 2018 Apr; 119(4):3326-3337. PubMed ID: 29125889
[TBL] [Abstract][Full Text] [Related]
15. N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-κB/p65.
Hou J; Wang T; Xie Q; Deng W; Yang JY; Zhang SQ; Cai JC
Cancer Lett; 2016 Jun; 376(1):22-33. PubMed ID: 27012186
[TBL] [Abstract][Full Text] [Related]
16. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
19. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
[TBL] [Abstract][Full Text] [Related]
20. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
